Nuwellis NUWE
NASDAQ NUWE
$1.13 -0.04 (-3.42%)
At close: Aug 20, 2026 · 1:21 PM UTC

Nuwellis (NUWE) Net Income towards Common Stockholders (2011 - 2026)

Nuwellis' (NUWE) quarterly Net Income towards Common Stockholders came in at -$4.5 million in Q1 2026, down 50.65% YoY from -$9.2 million in Q1 2025, and down 87.48% on a QoQ basis from -$2.4 million in Q4 2025.

Nuwellis (NUWE) Net Income towards Common Stockholders (2011 - 2026) Analysis & Trends

Nuwellis (NUWE) has 16 years of Net Income towards Common Stockholders data on file, last reported at -$4.5 million in Q1 2026.

  • Quarterly Net Income towards Common Stockholders fell 50.65% year-over-year to -$4.5 million in Q1 2026, while the trailing twelve-month figure through Mar 2026 was -$19.0 million (down 93.37% YoY) and the FY2025 annual result came in at -$17.5 million, down 64.88% from the prior year.
  • Net Income towards Common Stockholders eased to -$4.5 million in Q1 2026, from -$2.4 million in the prior quarter.
  • In the past five years, Net Income towards Common Stockholders ranged from a high of $2.4 million in Q3 2024 to a low of -$12.6 million in Q2 2025.
  • A 5-year average of -$4.1 million and a median of -$3.9 million in 2022 frame the typical range for Net Income towards Common Stockholders.
  • Annual changes were most pronounced in 2023 — Net Income towards Common Stockholders sank 476.93% — and 2024, when it surged 169.97%.
  • Tracing NUWE's Net Income towards Common Stockholders over 5 years: stood at -$1.4 million in 2022, then slumped by 476.93% to -$7.9 million in 2023, then soared by 81.48% to -$1.5 million in 2024, then sank by 64.92% to -$2.4 million in 2025, then plunged by 87.48% to -$4.5 million in 2026.
  • The last three Net Income towards Common Stockholders figures came in at -$4.5 million (Q1 2026), -$2.4 million (Q4 2025), and $469000.0 (Q3 2025), per Business Quant data.

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Net Income (Qtr)
1 Abbott Laboratories 199.07 Bn 193.46 Bn 7.27 Bn 928.00 Mn
2 Stryker 127.90 Bn 124.43 Bn 4.50 Bn 1.28 Bn
3 Medtronic 118.84 Bn 109.62 Bn 6.41 Bn 1.26 Bn
4 Boston Scientific 73.33 Bn 72.79 Bn 3.85 Bn 907.00 Mn
5 Edwards Lifesciences 51.93 Bn 47.68 Bn 1.35 Bn 241.40 Mn
6 Dexcom 34.46 Bn 32.51 Bn 830.00 Mn 249.10 Mn
7 GE HealthCare Technologies 33.91 Bn 31.81 Bn 2.18 Bn 574.00 Mn
8 Koninklijke Philips 26.36 Bn 23.04 Bn 4.55 Bn 621.86 Mn
9 Steris 23.12 Bn 22.64 Bn 684.20 Mn 201.00 Mn
10 Nuwellis 204,804.59 -3.72 Mn 1.50 Mn -4.83 Mn

Historic Data

Download Data
DateValue
Jun 30, 2026 -4.83 Mn
Mar 31, 2026 -4.54 Mn
Dec 31, 2025 -2.42 Mn
Sep 30, 2025 469,000.00
Jun 30, 2025 -12.55 Mn
Mar 31, 2025 -3.01 Mn
Dec 31, 2024 -1.47 Mn
Sep 30, 2024 2.36 Mn
Jun 30, 2024 -7.73 Mn
Mar 31, 2024 -3.79 Mn
Dec 31, 2023 -7.93 Mn
Sep 30, 2023 -3.37 Mn
Jun 30, 2023 -4.85 Mn
Mar 31, 2023 -6.49 Mn
Dec 31, 2022 -1.37 Mn
Sep 30, 2022 -3.87 Mn
Jun 30, 2022 -4.29 Mn
Mar 31, 2022 -4.47 Mn
Dec 31, 2021 15.82 Mn
Sep 30, 2021 -5.27 Mn